TLR4 and polycystic ovary syndrome: In PCOS models, it has been shown to suppress the Ox-LDL/TLR-4/NF-κB pathway, downregulating ovarian IL-1β, IL-6, and TNF-α expression (27), while also improving levels of SOD, CAT, and MDA to restore ovarian function (26).